Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
Saved in:
| Date: | 2018 |
|---|---|
| Main Author: | D. E. Ryspayeva |
| Format: | Article |
| Language: | English |
| Published: |
2018
|
| Series: | Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001148818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: Ryspayeva, D.E.
Published: (2018)
by: Ryspayeva, D.E.
Published: (2018)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)
by: I. P. Nesina, et al.
Published: (2019)
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)
by: Lyalkin, S.A., et al.
Published: (2023)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Prognostic value of blood redox-state indicators in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2018)
by: A. P. Burlaka, et al.
Published: (2018)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)
by: D. Y. Tsyhyka, et al.
Published: (2013)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)
by: Tsyhyka, D.Y., et al.
Published: (2013)
Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
by: N. A. Bondarovich, et al.
Published: (2008)
by: N. A. Bondarovich, et al.
Published: (2008)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
by: D. E. Ryspaeva, et al.
Published: (2017)
by: D. E. Ryspaeva, et al.
Published: (2017)
The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
by: Liubota, R., et al.
Published: (2017)
by: Liubota, R., et al.
Published: (2017)
Определение содержания CD44⁺CD24⁻ клеток как дополнительный критерий оценки эффективности превентивной терапии онкопатологии в эксперименте
by: Бондарович, Н.А., et al.
Published: (2008)
by: Бондарович, Н.А., et al.
Published: (2008)
Second-line chemotherapy in patients with advanced gastric cancer
by: V. G. Bondar, et al.
Published: (2014)
by: V. G. Bondar, et al.
Published: (2014)
Combination of chemotherapy and immunotherapy in cancer patients treatment (review)
by: N. E. Prokhach, et al.
Published: (2017)
by: N. E. Prokhach, et al.
Published: (2017)
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Secondary edematous breast cancer: when to be operated on background of neo-adjuvant chemotherapy?
by: O. M. Bilyi, et al.
Published: (2019)
by: O. M. Bilyi, et al.
Published: (2019)
Expression of anti-apoptothic protein survivin and gene BIRC5 in primary breast carcinoma as a prognostic marker for progression of disease
by: Ya. A. Shliakhtunou
Published: (2018)
by: Ya. A. Shliakhtunou
Published: (2018)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Characterization of breast cancer DNA content profiles as a prognostic tool
by: B. I. Gerashchenko, et al.
Published: (2014)
by: B. I. Gerashchenko, et al.
Published: (2014)
Characterization of breast cancer DNA content profiles as a prognostic tool
by: Gerashchenko, B.I., et al.
Published: (2014)
by: Gerashchenko, B.I., et al.
Published: (2014)
Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: S. Akyurek, et al.
Published: (2013)
by: S. Akyurek, et al.
Published: (2013)
Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)
by: Akyurek, S., et al.
Published: (2013)
Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018)
by: A. I. Rybin, et al.
Published: (2018)
Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
by: A. A. Mikhanovskij, et al.
Published: (2014)
by: A. A. Mikhanovskij, et al.
Published: (2014)
Interplay of host genome and tumour genome in bladder cancer
by: M. P. Smal, et al.
Published: (2019)
by: M. P. Smal, et al.
Published: (2019)
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)
by: Kirkilevsky, S.I., et al.
Published: (2023)
The expression of markers of epithelial-mesenchymal transition and drug resistance proteins as a prognostic indicator in patients with colorectal cancer
by: N. O. Bezdieniezhnykh, et al.
Published: (2016)
by: N. O. Bezdieniezhnykh, et al.
Published: (2016)
Expression of epithelial-mesenchymal transition-related genes in prostate tumours
by: Gerashchenko, G.V., et al.
Published: (2017)
by: Gerashchenko, G.V., et al.
Published: (2017)
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
by: Buchynska, L.G., et al.
Published: (2009)
by: Buchynska, L.G., et al.
Published: (2009)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Human microbiota and effectiveness of cancer chemotherapy
by: Shvets, Yu.V., et al.
Published: (2023)
by: Shvets, Yu.V., et al.
Published: (2023)
Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
by: A. N. Dubinina
Published: (2016)
by: A. N. Dubinina
Published: (2016)
CD8 and CD45RO T lymphocytes in bone marrow of gastric cancer patients: correlation with disseminated tumor cells and disease outcome
by: S. Osinsky, et al.
Published: (2015)
by: S. Osinsky, et al.
Published: (2015)
Similar Items
-
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: Ryspayeva, D.E.
Published: (2018) -
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017) -
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018) -
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017) -
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)